November 2023
In this MindMatters: discover how you can turn hope into action; meet new ABTA-funded researchers and apply now for 2024 grants; read top news highlights of 2023; and explore a caregiver’s six tips for National Family Caregivers Month.
November 2023
In this MindMatters: discover how you can turn hope into action; meet new ABTA-funded researchers and apply now for 2024 grants; read top news highlights of 2023; and explore a caregiver’s six tips for National Family Caregivers Month.
Your Support Turns Hope Into Action
Join us in our mission to accelerate research breakthroughs and fuel hope for brain tumor patients and families.
Top Brain Tumor News & Milestones for 2023
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
Six Tips From My Experience As a Caregiver
For National Family Caregivers Month, Robin Ferrill shares tips from her experience embracing the role after her husband’s GBM diagnosis in 2022.
The ABTA announces the funding of $1.3 million in new brain tumor research grants.
Calling all researchers: the ABTA is now accepting applications for 2024 research grants and fellowships.
Six Tips From My Experience As a Caregiver
For National Family Caregivers Month, Robin Ferrill shares tips from her experience embracing the role after her husband’s GBM diagnosis in 2022.
Top Brain Tumor News & Milestones for 2023
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
Your Support Turns Hope Into Action
Join us in our mission to accelerate research breakthroughs and fuel hope for brain tumor patients and families.
The ABTA announces the funding of $1.3 million in new brain tumor research grants.
Calling all researchers: the ABTA is now accepting applications for 2024 research grants and fellowships.
Popular Stories
Research Update: DCVax-L Phase 3 Clinical Trial Data Published for GBM
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
Brain Tumor Survivor Shares Top Three National Conference Takeaways
After losing her husband to GBM in 2022 and receiving her own diagnosis, survivor Beth Kassab didn’t know what to expect attending the largest brain tumor conference in Chicago. Read Beth’s top takeaways:
“Doing Hard Things” Community Bands Together to Drive Kelli McLaughlin’s Legacy Forward
Family and friends of Kelli McLaughlin are doing the hardest things: turning their grief into action to carry on Kelli’s legacy and vision of a future without brain tumors.
Popular Stories
“Doing Hard Things” Community Bands Together to Drive Kelli McLaughlin’s Legacy Forward
Family and friends of Kelli McLaughlin are doing the hardest things: turning their grief into action to carry on Kelli’s legacy and vision of a future without brain tumors.
Brain Tumor Survivor Shares Top Three National Conference Takeaways
After losing her husband to GBM in 2022 and receiving her own diagnosis, survivor Beth Kassab didn’t know what to expect attending the largest brain tumor conference in Chicago. Read Beth’s top takeaways:
Research Update: DCVax-L Phase 3 Clinical Trial Data Published for GBM
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
